Evidence map›Paper›PMID 27695365›Full record

ArticleInternational journal of women's health2016

Continuation rates, bleeding profile acceptability, and satisfaction of women using an oral contraceptive pill containing estradiol valerate and dienogest versus a progestogen-only pill after switching from an ethinylestradiol-containing pill in a real-life setting: results of the CONTENT study.

Paula Briggs, Marco Serrani, Kai Vogtländer, Susanne Parke

Open access · goldAbstract read
In one paragraph

Article in International journal of women's health, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 26 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 3 countries.

Paula BriggsSexual and Reproductive Health, Southport and Ormskirk Hospital NHS Trust, Merseyside, UK.
Marco SerraniGlobal Medical Affairs Women's HealthCare, Bayer Pharma AG, Berlin.
Kai VogtländerGlobal Integrated Analysis & Life Cycle Management Statistics, Bayer Pharma AG, Wuppertal.
Susanne ParkeGlobal Clinical Development Women's HealthCare, Bayer Pharma AG, Berlin, Germany.
Bayer (Germany) · DESouthport and Ormskirk Hospital NHS Trust · GBWomen’s Health Care · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOral contraceptives are still associated with high discontinuation rates, despite their efficacy. There is a wide choice of oral contraceptives available, and the aim of this study was to assess continuation rates, bleeding profile acceptability, and the satisfaction of women in the first year of using a contraceptive pill containing estradiol valerate and dienogest (E METHODS AND

resultsIn this prospective, noninterventional, observational study, 3,152 patients were included for the efficacy analyses (n=2,558 women in the E

conclusionThe E

Indexed as

compliancecontraceptiondienogestestradiol valerateoral contraceptive

Identifiers

PMID27695365
PMCPMC5029837
OpenAlexW2519073709

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.